Nanna Therapeutics

Drug discovery: A new way - Charting unexplored regions of chemical space - Ultra-high-throughput phenotypic screening - Evolution driving the selection of disease-curing drugs Bactevo has a proprietary disruptive platform technology for discovering new small molecule drugs and is looking for partners to expand the impact of this platform and further its use in all disease areas. Instead of using huge medicinal chemistry resource and high-throughput microtiter plate-based screening, Bactevo uses billions of different engineered microbes combined with ultra-HT microfluidic phenotypic screening to select the best small molecules giving the desired biological effect. In addition to accessing new chemical space, the platform accesses small molecules synthesized by biological systems and therefore are likely to advance more quickly through discovery and development. The platform has already been validated in drug discovery with a top 5 Pharma.